Piramal Pharma Solutions

Piramal Pharma Solutions (PPS) is a globally recognized Contract Development and Manufacturing Organization (CDMO) offering integrated drug development, manufacturing, and commercialization services to pharmaceutical and biotechnology companies worldwide. As a part of Piramal Pharma Limited, the company is headquartered in Mumbai, India, and operates a broad international network of development centers and manufacturing facilities across North America, Europe, and Asia.

Piramal Pharma Solutions provides comprehensive services covering drug discovery support, process development, analytical testing, clinical trial manufacturing, commercial manufacturing, sterile injectables, biologics, antibody-drug conjugates (ADCs), high-potency APIs, peptide development, and specialized dosage forms. Its integrated capabilities allow clients to move seamlessly from early-stage research through regulatory approval and commercial production.

The company serves emerging biotechnology firms as well as many of the world’s leading pharmaceutical organizations. Its facilities comply with global regulatory standards established by the US FDA, EMA, MHRA, PMDA, and other international health authorities. Piramal continuously invests in advanced manufacturing technologies, sustainability, digital transformation, and scientific innovation to strengthen its global service portfolio.

With decades of pharmaceutical manufacturing experience, strong regulatory expertise, and customer-focused development programs, Piramal Pharma Solutions has become one of the world’s most trusted CDMO partners, supporting the development of innovative therapies across multiple therapeutic areas.